• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Consumer Cyclical·8281.HK
Share

China Golden Classic Group Limited Stocks

HK$ 0.25Last Updated 26.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

HK$ 31.89M

HK$ 0.25
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

China Golden Classic Group Limited operates as an investment holding company, primarily engaged in the production and distribution of oral care, leather care, and household hygiene products. Its market presence extends across China, the United States, Australia, and various other international regions. The company's oral hygiene offerings encompass a range of items such as functional toothpaste, mouthwash, oral sprays, and toothbrushes. Beyond dental products, it also specializes in manufacturing and selling diverse leather maintenance solutions, including specific products designed for shoes and apparel. Furthermore, its household product portfolio features surface cleaners, laundry care essentials, toilet sanitation products, and anti-mould treatments. Established in 2015, the firm maintains its headquarters in Jiangyin, located within the People's Republic of China.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 13:34

Outflows from tech stocks, a rocky start, and market distortions: Why Anthropic’s IPO Is Risky

27.10.2026 13:07

Hot Dogs vs. Squid. Will Netflix Save Its Business With a New Strategy?

27.10.2026 12:01

Top Stories This Morning: Intel to Acquire Quantum Startup, DoorDash in Talks for a $17 Billion Deal

27.10.2026 11:18

Stocks in South Korea and Japan surged on news of Anthropic's IPO. Is it time to buy?

27.10.2026 09:01

Anthropic's need for capital is growing. Will it receive an investment rating?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026